Target intelligence / Profile preview

Bone marrow hematopoietic progenitor cells (HSPC)

Target
HSPC
Molecular classification
Other (cell population), The cells themselves express molecular markers such as CD34, c-Kit (CD117), Sca-1, etc., but the population is not a molecule/receptor
01

Overview

Bone marrow hematopoietic progenitor cells are a diverse group of immature blood-forming cells residing in the bone marrow, responsible for the continuous regeneration of all blood cell types, including lymphoid and myeloid lineages. They include both long-term self-renewing hematopoietic stem cells (HSCs) and lineage-committed multipotent or oligopotent progenitors. These cells are essential for normal hematopoiesis, can be therapeutically harnessed in bone marrow transplantation, and are implicated in malignancies such as leukemia when their differentiation or self-renewal capacity is dysregulated. Their identification relies on specific cell surface antigens (e.g., CD34, c-Kit), and they are studied as targets for both regenerative medicine and chemotherapeutic strategies, but the population itself is not a receptor or discrete molecular entity.

Other names
Hematopoietic progenitor cellHematopoietic stem cell (HSC)Bone marrow stem cellHSPC
02

Biological functions

Cell proliferationSelf-renewalDifferentiation into myeloid and lymphoid lineagesTissue regenerationBlood cell formation (hematopoiesis)
03

Disease associations

Cancer (leukemia, myelodysplastic syndrome)Bone marrow failureRegenerative medicine (bone marrow transplantation)Other (immune deficiency disorders, anemia)
04

Safety considerations

Risk of graft-versus-host disease following transplantationMyelosuppression with chemotherapeutic targetingClonal evolution and risk of malignant transformation (e.g., leukemia, MDS)Infection risk due to immune deficiency if depleted
05

Biomarkers

CD34 (used clinically to identify and isolate HSPCs for transplantation)c-Kit (CD117)Sca-1CD133

Beyond the preview

Go deeper on Bone marrow hematopoietic progenitor cells (HSPC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone marrow hematopoietic progenitor cells (HSPC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call